Form 4: Carlyle Group Sells QuidelOrtho Corp Shares Under 10b5-1 Plan

The Carlyle Group executed multiple sales of QuidelOrtho Corp (QDEL) common stock on July 30 and 31, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• The Carlyle Group, a significant shareholder of QuidelOrtho Corp (QDEL), reported the sale of common stock on July 30 and 31, 2024.
• The sales were executed under a Rule 10b5-1 trading plan adopted on May 12, 2024.
• On July 30, 2024, sales occurred at weighted average prices of $38.9331, $39.7411, and $40.0173.
• On July 31, 2024, sales occurred at weighted average prices of $38.674 and $39.2708.
• Following these transactions, Carlyle Partners VI Cayman Holdings, L.P. beneficially owns 9,128,748 shares of QuidelOrtho Corp.
• The Carlyle Group Inc. and related entities disclaim beneficial ownership of these securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting share sales. It doesn't convey any explicit positive or negative sentiment, but the sales themselves could be interpreted as slightly negative, though they are part of a pre-arranged plan.

Industry Context

Share sales by major holders like Carlyle Group are common and can be part of portfolio management strategies. The use of a 10b5-1 plan indicates that these sales were pre-planned and not based on recent market information.

Stakeholder Impact

• The share sales could potentially exert downward pressure on the stock price in the short term.
• The sales by a major shareholder may influence investor sentiment.

Key Dates